The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Elbasvir/grazoprevir (EBR/GZR) is an all‐oral direct‐acting antiviral agent (DAA) with high sustained virologic response (SVR) in clinical trials. This study's primary objective was to evaluate effectiveness of EBR/GZR among HCV‐infected patients in a real‐world clinical setting. We conducted a nationwide retrospective observational cohort study of HCV‐infected patients in the US Department of Veterans...
There are gender‐specific variations in the epidemiology and clinical course of hepatitis C virus (HCV) infection. However, few long‐term longitudinal studies have examined trends in the incidence and prevalence of serious liver complications among women compared with men with HCV infection.
We used the Veterans Administration Corporate Data Warehouse to identify all veterans with positive HCV...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.